AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zicla-M Tablet

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Zicla-M Tablet

DiabetaComb tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. This medication helps regulate blood glucose. DiabetaComb should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this is part of a comprehensive diabetes management plan that includes a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital for diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential to manage hypoglycemia. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to monitor blood cell counts and liver function.

Primary Ingredients of Zicla-M Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Zicla-M Tablet

Diabetes type 2

Major Benefits of Zicla-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zicla-M Tablets should be administered with a meal.

Common Side effects of Zicla-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Zicla-M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zicla-M Tablets should be administered with food.

How Zicla-M Tablet works:

Zicla-M tablets contain a dual-action formulation of gliclazide and metformin, both of which help manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Zicla-M tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Zicla-M tablets during pregnancy poses a confirmed risk to the unborn child and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zicla-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Zicla-M Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Zicla-M Tablets are contraindicated in individuals with severely compromised kidney function. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Zicla-M tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial Zicla-M tablet dosage is typical; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Zicla-M Tablet :

Should you forget a Zicla-M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Zicla-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Zicla-M Tablet

Zicla-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Zicla-M is unsuitable for type 1 diabetes.
Zicla-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Zicla-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Zicla-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely to occur if you avoid using the medication if you have kidney disease, are elderly, or consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Zicla-M immediately and seek medical attention.
Prolonged Zicla-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Zicla-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Zicla-M Tablet and alcohol is unsafe. This combination may cause dangerously low blood sugar and increase the risk of lactic acidosis.
Zicla-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Zicla-M is not suitable for type 1 diabetes.
Zicla-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Zicla-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Zicla-M Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zicla-M immediately and seek medical attention.
Prolonged Zicla-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Zicla-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Zicla-M Tablet with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Zicla-M Tablet
67
MRP 77
12% off